Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 774 (ZNF774) is a member of the C2H2-type zinc finger protein family, which is the largest transcription factor family in the human genome. ZNF774 is a protein-coding gene predicted to function primarily as a DNA-binding transcription factor that regulates gene expression by binding to specific DNA sequences and modulating transcription by RNA polymerase II[4][7][15]. These proteins usually act in the nucleus and may be involved in a range of regulatory pathways controlling gene activity, but ZNF774 itself has not been specifically described as a therapeutic target, nor has it been directly implicated in major disease processes or targeted by drugs at this time. The molecular function is inferred by homology to other zinc finger proteins, and there is no direct evidence linking ZNF774 to specific physiological or pathological roles[4][7][15].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 774 (ZNF774).